Machine Learning in Cardiology—Ensuring Clinical Impact Lives Up to the Hype

Author:

Russak Adam J.12,Chaudhry Farhan3,De Freitas Jessica K.24,Baron Garrett3,Chaudhry Fayzan F.24,Bienstock Solomon1,Paranjpe Ishan2,Vaid Akhil24,Ali Mohsin5,Zhao Shan26,Somani Sulaiman2,Richter Felix24ORCID,Bawa Tejeshwar3,Levy Phillip D.3,Miotto Riccardo24,Nadkarni Girish N.2789,Johnson Kipp W.24ORCID,Glicksberg Benjamin S.24ORCID

Affiliation:

1. Department of Internal Medicine, Mount Sinai Hospital, New York, NY, USA

2. Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, USA

3. Department of Emergency Medicine and Integrative Biosciences Center, Wayne State University, Detroit, MI, USA

4. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

5. Department of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA

6. Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

7. Division of Nephrology, Mount Sinai Hospital, New York, NY, USA

8. Division of Cardiology, Mount Sinai Hospital, New York, NY, USA

9. Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Abstract

Despite substantial advances in the study, treatment, and prevention of cardiovascular disease, numerous challenges relating to optimally screening, diagnosing, and managing patients remain. Simultaneous improvements in computing power, data storage, and data analytics have led to the development of new techniques to address these challenges. One powerful tool to this end is machine learning (ML), which aims to algorithmically identify and represent structure within data. Machine learning’s ability to efficiently analyze large and highly complex data sets make it a desirable investigative approach in modern biomedical research. Despite this potential and enormous public and private sector investment, few prospective studies have demonstrated improved clinical outcomes from this technology. This is particularly true in cardiology, despite its emphasis on objective, data-driven results. This threatens to stifle ML’s growth and use in mainstream medicine. We outline the current state of ML in cardiology and outline methods through which impactful and sustainable ML research can occur. Following these steps can ensure ML reaches its potential as a transformative technology in medicine.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3